Statements of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Sep. 29, 2012	Oct. 01, 2011	Sep. 29, 2012	Oct. 01, 2011
Revenues:
Product sales	$ 2,605,465	$ 4,508,250	$ 9,477,790	$ 13,848,477
Product sales under coopertive agreement	138,716	392,790	449,432	1,734,668
Total Revenues	2,744,181	4,901,040	9,927,222	15,583,145
Cost of product sales	2,862,384	3,651,046	9,620,401	11,250,968
Cost of Research and development under cooperative agreement	117,904	358,002	383,789	1,624,710
Gross Margin	(236,107)	891,992	(76,968)	2,707,467
Selling, general and administrative expense	641,046	835,375	2,294,778	2,579,388
Operating income (loss)	(877,153)	56,617	(2,371,746)	128,079
Interest expense, net	(4,792)	(8,528)	(16,258)	(26,264)
Net income (loss) before income tax expense (benefit)	(881,945)	48,089	(2,388,004)	101,815
Income tax expense (benefit)	(351,000)	20,500	(950,000)	44,900
Net income (loss)	$ (530,945)	$ 27,589	$ (1,438,004)	$ 56,915
Net income (loss) basic common share	$ (0.04)	$ 0.00	$ (0.11)	$ 0.00
Weighted average number of basic common shares outstanding	12,871,659	12,748,149	12,868,934	12,733,312
Net income (loss) per diluted common share	$ (0.04)	$ 0.00	$ (0.11)	$ 0.00
Weighted average number of diluted common shares outstanding	12,871,659	13,190,317	12,868,934	13,199,666